TY - JOUR A1 - Pietsch, Ullrich A1 - Kubowicz, Stephan A1 - Thünemann, Andreas F. A1 - Geue, Thomas A1 - Watson, M. D. A1 - Tchebotareva, N. A1 - Müllen, K. T1 - X-ray reflectivity study of an amphiphilic hex-peri-hexabenzocoronene at a structured silicon wafer surface Y1 - 2003 ER - TY - JOUR A1 - Former, C. A1 - Wagner, H. A1 - Richert, R. A1 - Neher, Dieter A1 - Müllen, K. T1 - Orientation and dynamics of chainlike dipole arrays: Donor-acceptor-substituted oligophenylenevinylenes in a polymer matrix Y1 - 1999 ER - TY - JOUR A1 - Qu, J. Q. A1 - Zhang, J. Y. A1 - Grimsdale, A. C. A1 - Mullen, K. A1 - Jaiser, Frank A1 - Yang, X. H. A1 - Neher, Dieter T1 - Dendronized perylene diimide emitters : Synthesis, luminescence, and electron and energy transfer studies N2 - Aggregation of chromophores in the solid state commonly causes undesirable red shifts in the emission spectra and/or emission quenching. To overcome this problem, we have prepared soluble perylenetetracarboxidiimide dyes in which the chromophores are effectively shielded by polyphenylene dendrimers attached in the bay positions. Models show that attachment of the shielding units in the bay position should provide more efficient shielding than attaching them via the imide moieties. The dendrimers possess excellent film-forming properties due to alkyl substituents on their peripheries. The lack of a red shift in emission upon going from solution to the solid state indicates the dendrons suppress interaction of the emissive cores, leading to pure red-orange emission. Single-layer LEDs produce red-orange emission with relatively low efficiency especially for the higher generation dendrons, which is attributed to poor charge conduction. LEDs using blends of the dendrimers and the undendronized dye as a model compound in PVK have been investigated, and a model to extract relative charge injection rates through the dendritic scaffold from the spectral contributions in the EL spectra is developed Y1 - 2004 SN - 0024-9297 ER - TY - JOUR A1 - Sigel, Keith Magnus A1 - Swartz, Talia H. A1 - Golden, Eddye A1 - Paranjpe, Ishan A1 - Somani, Sulaiman A1 - Richter, Felix A1 - De Freitas, Jessica K. A1 - Miotto, Riccardo A1 - Zhao, Shan A1 - Polak, Paz A1 - Mutetwa, Tinaye A1 - Factor, Stephanie A1 - Mehandru, Saurabh A1 - Mullen, Michael A1 - Cossarini, Francesca A1 - Böttinger, Erwin A1 - Fayad, Zahi A1 - Merad, Miriam A1 - Gnjatic, Sacha A1 - Aberg, Judith A1 - Charney, Alexander A1 - Nadkarni, Girish A1 - Glicksberg, Benjamin S. T1 - Coronavirus 2019 and people living with human immunodeficiency virus BT - outcomes for hospitalized patients in New York City JF - Clinical infectious diseases : electronic edition N2 - Background: There are limited data regarding the clinical impact of coronavirus disease 2019 (COVID-19) on people living with human immunodeficiency virus (PLWH). In this study, we compared outcomes for PLWH with COVID-19 to a matched comparison group. Methods: We identified 88 PLWH hospitalized with laboratory-confirmed COVID-19 in our hospital system in New York City between 12 March and 23 April 2020. We collected data on baseline clinical characteristics, laboratory values, HIV status, treatment, and outcomes from this group and matched comparators (1 PLWH to up to 5 patients by age, sex, race/ethnicity, and calendar week of infection). We compared clinical characteristics and outcomes (death, mechanical ventilation, hospital discharge) for these groups, as well as cumulative incidence of death by HIV status. Results: Patients did not differ significantly by HIV status by age, sex, or race/ethnicity due to the matching algorithm. PLWH hospitalized with COVID-19 had high proportions of HIV virologic control on antiretroviral therapy. PLWH had greater proportions of smoking (P < .001) and comorbid illness than uninfected comparators. There was no difference in COVID-19 severity on admission by HIV status (P = .15). Poor outcomes for hospitalized PLWH were frequent but similar to proportions in comparators; 18% required mechanical ventilation and 21% died during follow-up (compared with 23% and 20%, respectively). There was similar cumulative incidence of death over time by HIV status (P = .94). Conclusions: We found no differences in adverse outcomes associated with HIV infection for hospitalized COVID-19 patients compared with a demographically similar patient group. KW - human immunodeficiency virus KW - coronavirus 2019 KW - severe acute respiratory KW - syndrome coronavirus 2 Y1 - 2020 U6 - https://doi.org/10.1093/cid/ciaa880 SN - 1058-4838 SN - 1537-6591 VL - 71 IS - 11 SP - 2933 EP - 2938 PB - Oxford Univ. Press CY - Cary, NC ER -